(Q47979978)

7 February 2018

title

Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system (English)

1 reference

7 February 2018

author

Geoffrey A Allen

1

1 reference

7 February 2018

Maureane Hoffman

4

1 reference

7 February 2018

Dougald M. Monroe

6

1 reference

7 February 2018

author name string

Wolberg AS

2

1 reference

7 February 2018

Oliver JA

3

1 reference

7 February 2018

Roberts HR

5

1 reference

7 February 2018

publication date

1 March 2004

1 reference

7 February 2018

Journal of Thrombosis and Haemostasis

published in

1 reference

7 February 2018

volume

2

1 reference

7 February 2018

issue

3

1 reference

7 February 2018

page(s)

402-413

1 reference

7 February 2018

A rapid method to isolate platelets from human blood by density gradient centrifugation

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2003.00617.X

The production of an inactive form of antithrombin through limited proteolysis by thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2003.00617.X

Congenital factor X deficiency: spectrum of bleeding symptoms in 32 Iranian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2003.00617.X

Coagulation factors II, V, VII, and X, prothrombin gene 20210G-->A transition, and factor V Leiden in coronary artery disease: high factor V clotting activity is an independent risk factor for myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2003.00617.X

Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2003.00617.X

Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2003.00617.X

Variability in platelet procoagulant activity in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2003.00617.X

Thrombin functions during tissue factor-induced blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2003.00617.X

Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2003.00617.X

Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2003.00617.X

Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2003.00617.X

High levels of coagulation factor XI as a risk factor for venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2003.00617.X

10.1111/J.1538-7933.2003.00617.X

21 January 2018

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018